2026 AAPS National Biotechnology Conference
Tradeshow
|
San Diego, California
|
Americas
Add to Calendar
Add to Calendar
2026-05-11T00:00:00
2026-05-14T23:59:59
2026 AAPS National Biotechnology Conference
<h2>Attending AAPS NBC 2026?</h2><p>Join us at the AAPS National Biotechnology Conference (NBC) for a Learning Lab session focused on advancing immunogenicity assessment for next‑generation <em>Shigella</em> vaccines.</p><p><em>Shigella</em> remains a major cause of diarrheal disease in young children worldwide, particularly in low‑ and middle‑income countries (LMICs), driving the need for broadly protective vaccines. <span> </span></p><p>This session will explore the development and qualification of a multiplexed immunoassay designed to assess vaccine‑induced immunogenicity for <em>Shigella</em>, supporting early‑phase clinical studies and global standardization efforts.</p><hr size="2" width="100%" align="center"><h3><strong>Agenda</strong></h3><p><strong>Wednesday, May 13</strong><br><strong>3:30 - 4:15 p.m. (CDT)</strong></p><p><strong>Learning Lab Session (Exhibit Hall)</strong><br><em>Development and qualification of a multiplexed immunoassay to assess the Immunogenicity of Shigella vaccines.<span> </span></em></p><p>Paul Rhyne, PhD, Senior Director, Scientific Solutions, Luminex</p><p><strong>Location</strong><br>Learning Lab – Exhibit Hall</p><hr size="2" width="100%" align="center"><h3><strong>Session Overview</strong></h3><p><em>Shigella</em> is a major cause of diarrheal disease in young children worldwide, particularly in LMICs. Several next-generation <em>Shigella</em> vaccines are under development to achieve broad protective coverage. A multiplexed assay to measure vaccine‑induced seroreactivity to <em>S. sonnei</em> and <em>S. flexneri</em> serotypes, IpaB, and common vaccine carrier proteins was developed and qualified for use in early clinical studies. The qualification results will be presented and discussed.</p><hr size="2" width="100%" align="center"><p><strong>Learning Objectives Include:</strong></p><ul style="list-style-type:disc;padding-left:96px;"><li>Application of multiplexed assays to support multivalent vaccines.<ul style="list-style-type:disc;padding-left:0px;"><li>Qualification of multiplexed assays to support early phase clinical studies.</li><li>Global efforts to standardize the measurement of seroreactivity to multiple <em>Shigella </em>species and serotypes.</li></ul></li></ul><p><strong>Registration:</strong> No registration required<br><strong>Food:</strong> No food provided</p><p>Discover more: <a href="https://www.aaps.org/nbc">NBC - American Association of Pharmaceutical Scientists</a></p>
San Diego, California
Diasorin
diasorin@nomail.com
UTC
public
